Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bayer AG | 39 | 5 | 2 | 0 | €51.58 | €73.00 | 41.528% |
| Pfizer Inc. | 28 | 2 | 1 | 0 | €28.76 | €36.28 | 26.158% |
| Evotec AG | 29 | 3 | 0 | 0 | €29.37 | €39.00 | 32.789% |
| Johnson & Johnson | 19 | 1 | 2 | 0 | €130.22 | €144.00 | 10.582% |
| AbbVie Inc. | 16 | 1 | 1 | 0 | €88.18 | €100.00 | 13.404% |
| Bristol-Myers Squibb | 13 | 0 | 0 | 0 | €50.02 | €60.32 | 20.582% |
| Canopy Growth Corp | 15 | 3 | 3 | 0 | €24.05 | €55.00 | 128.738% |
| Novo Nordisk A/S | 12 | 1 | 0 | 0 | €57.62 | €66.00 | 14.544% |
| Abbott Laboratories | 11 | 1 | 1 | 0 | €96.49 | €109.95 | 13.950% |
| Palatin Technologies | 12 | 2 | 1 | 0 | €0.56 | €1.05 | 86.899% |
| MorphoSys AG | 12 | 2 | 0 | 0 | €81.28 | €124.00 | 52.559% |
| Paion AG | 11 | 2 | 1 | 0 | €2.22 | €4.00 | 80.180% |
| Vertex Pharmaceuticals Inc. | 10 | 1 | 0 | 0 | €173.92 | €260.00 | 49.494% |
| GW Pharmaceuticals plc ADR | 9 | 1 | 1 | 0 | €180.00 | €190.57 | 5.874% |
| Merck KGaA | 10 | 2 | 1 | 0 | €130.30 | €137.00 | 5.142% |
| Bausch Health Companies Inc. | 9 | 1 | 1 | 0 | €26.02 | €29.30 | 12.627% |
| Alexion Pharmaceutical Inc. | 9 | 1 | 0 | 0 | €124.68 | €131.00 | 5.069% |
| Formycon AG | 8 | 1 | 2 | 0 | €60.20 | €80.00 | 32.890% |
| Amgen Inc. | 9 | 2 | 0 | 1 | €187.16 | €227.50 | 21.554% |
| Aphria Inc. | 10 | 3 | 1 | 1 | €12.00 | €19.80 | 64.973% |
| Exelixis Inc. | 7 | 0 | 0 | 0 | €18.00 | €27.50 | 52.778% |
| Eli Lilly Corp. | 8 | 1 | 0 | 0 | €170.80 | €165.00 | -3.396% |
| Sarepta Therapeutics | 9 | 2 | 1 | 0 | €70.29 | €153.34 | 118.153% |
| QIAGEN NV | 9 | 2 | 0 | 1 | €39.18 | €44.73 | 14.156% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 8 | 1 | 0 | 0 | €8.78 | €12.11 | 37.870% |
